Previous Page  22 / 24 Next Page
Information
Show Menu
Previous Page 22 / 24 Next Page
Page Background

Page 49

Volume 05

Journal of Clinical Nutrition & Dietetics

ISSN: 2472-1921

JOINT EVENT

June 17-18, 2019 London, UK

Nutrition World 2019

Euro Obesity 2019

June 17-18, 2019

&

26

th

World Nutrition Congress

15

th

Euro Obesity and Endocrinology Congress

Advanced glycation end products

Raquel Lima

Institute Kurz, Germany

Statement:

Advanced glycation end-products (AGEs) are a complex group of molecules that have been found almost

everywhere among tissues and organs of the human body and they come not only from an endogenous formation,

but also from exogenous dietary exposure. Their concentration increases with age and a persistent exposure to

elevated levels of endogenous and exogenous AGEs are thought to contribute to the pathogenesis and progression

of a variety of chronic conditions, including type 1 diabetes, type 2 diabetes, neurodegenerative conditions, allergy,

nonalcoholic steatohepatitis, asthma, inflammatory bowel disease, renal disease, and certain cancers. The human

body has evolved a number of detoxification systems to reduce the burden associated with AGEs and their dicarbonyl

precursors. Besides, limiting the dietary intake of foods that have undergone browning by the application of intense

heat, particularly food and beverages containing high levels of protein or carbohydrate derived from simple sugars,

would significantly reduce AGEs consumption. By considering the diverse pathways leading to AGEs formation,

there are also molecular strategies for the inhibition of their formation like the following: antioxidants, metal ion

chelators and compounds able to quench reactive carbonyl species (RCS) which act as AGEs. Another strategy to

lessen the accumulation and to provide protection against the

in vivo

formation of AGEs is to use nutraceuticals that

contain active ingredients derived from foods (e.g., vitamins, amino acids, antioxidants). Combination therapies that

simultaneously target multiple pathways may be more successful than those that modify a single pathway.

r.lima@institut_kurz.de raquel@nutralima.com

J Clin Nutr Diet 2019, Volume 05